Geographical clustering of amyotrophic lateral sclerosis in south-east England: A population study

Neuroepidemiology

Volumn 32, Issue 2, 2009, Pages 81-88

  Scott, Kirsten M ^a   Abhinav, Kumar ^b   Stanton, Biba R ^b   Johnston, Clare ^b   Turner, Martin R ^b   Ampong, Mary Ann ^c   Sakel, Mohamed ^e   Orrell, Richard W ^d   Howard, Robin ^d   Shaw, Christopher E ^b   Leigh, P Nigel ^b   Al Chalabi, Ammar ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^e EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Geographical distribution; Motor neuron disease; Population study

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION RESEARCH; REGISTER; RISK ASSESSMENT; RISK FACTOR; UNITED KINGDOM;

AMYOTROPHIC LATERAL SCLEROSIS; CLUSTER ANALYSIS; ENGLAND; FEMALE; HUMANS; MALE; POPULATION; REGISTRIES; RISK FACTORS;

EID: 56749106209     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000177032     Document Type: Article

References (22)

1. Sabel CE, Boyle PJ, Loytonen M, Gatrell AC, Jokelainen M, Flowerdew R, Maasilta P: Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. Am J Epidemiol 2003;157:898-905.
2. Johnston CA, Stanton BR, Turner MR, Gray R, Blunt AH, Butt D, Ampong MA, Shaw CE, Leigh PN, Al-Chalabi A: Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol 2006;253:1642-1643.
3. Mitchell JD: Amyotrophic lateral sclerosis: Toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord 2000:235-250.
4. Nelson LM, McGuire V, Longstreth WT, Matkin C: Population-based case-control study of amyotrophic lateral sclerosis in western Washington state. 1. Cigarette smoking and alcohol consumption. Am J Epidemiol 2000;151:156-163.
5. Boillee S, Van de Velde C, Cleveland DW: ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006;52:39-59.
6. Lewis M, Gordon PH: Lou Gehrig, rawhide, and 1938. Neurology 2007;68:615-618.
7. Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell JW, Howard R, Clarke J, Sakel M, Ampong MA, Shaw CE, Leigh PN, Al-Chalabi A: Amyotrophic lateral sclerosis in south-east England: a population based study [south-east England register for amyotrophic lateral sclerosis (SEALS) registry]. Neuroepidemiol 2007;29:44-48.
8. Office for National Statistics: Census 2001: Key statistics for postcode sectors in England and Wales. London, ONS, 2001. Available on CD from customerservices@ons.gov.uk.
9. Office for National Statistics: Commissioned table C0381, received 18/07/07. London, ONS, 2007. http://www.statistics.gov.uk/census2001/downloads/ com-tab-finder.xls (accessed 24/04/2008).
10. Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G: Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. J Neurol Neurosurg Psychiatry 1998;65:842-847.
11. Taylor JA, Davis JP: Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. J Clin Epidemiol 1989;42:569-575.
12. Waring SC, Esteban-Santillan C, Reed DM, Craig UK, Labarthe DR, Petersen RC, Kurland LT: Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950-1989. Neuroepidemiology 2004;23:192-200.
13. Kokubo Y, Kuzuhara S, Narita Y: Geographical distribution of amyotrophic lateral sclerosis with neurofibrillary tangles in the Kii peninsula of Japan. J Neurol 2000;247:850-852.
14. Foster HD: Health, Disease and the Environment. London, Belhaven Press, 1992, pp 439-478.
15. Betemps EJ, Buncher CR: Birthplace as a risk factor in motor neurone disease and Parkinson's disease. Int J Epidemiol 1993;22:898-904.
16. Bharucha N: Geographic distribution of motor neuron disease and correlation with possible etiologic factors. Neurology 1983;33:911.
17. Gunnarsson LG, Lygner PE, Veiga-Cabo J, de Pedro-Cuesta J: An epidemic-like cluster of motor neuron disease in a Swedish county during the period 1973-1984. Neuroepidemiology 1996;15:142-152.
18. Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, Mastrantonio M, Vanacore N: Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol 2007.
19. Sutedja NA, Veldink JH, Fischer K, Kromhout H, Wokke JH, Huisman MH, Heederik DJ, Van den Burg LH: Lifetime occupation, education, smoking, and risk of ALS. Neurology 2007;69:1508-1514.
20. Al-Chalabi A, Andersen PM, Chioza B, Shaw C, Sham PC, Robberecht W, Matthijs G, Camu W, Marklund SL, Forsgren L, Rouleau G, Laing NG, Hurse PV, Siddique T, Leigh PN, Powell JF: Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet 1998;7:2045-2050.
21. Ceroni M, Malaspina A, Poloni TE, et al: Clustering of ALS patients in central Italy due to the occurrence of the L84F SOD1 gene mutation. Neurology 1999;53:1064.
22. Malaspina A, Alimonti D, Poloni TE, Ceroni M: Disease clustering: the example of ALS, PD, dementia and hereditary ataxias in Italy. Funct Neurol 2002;17:177-182.